	Exploring Emotional and Cognitive Perceptions of Cervical Cancer Screening and Self-Sampling Among Vulnerable Romanian Women: A Qualitative Study. Health Expect Pa, T, Greenley R, Kirkegaard P, Bøje RB, McKee M, Bardou M, B, and the CBIG. PMID: 41321069 [PubMed - indexed for MEDLINE]
	From residual risk to precision intervention: the evolving role of minimal residual disease in breast cancer management. Cancer Biol Med Xu J, Fang K, Li X, Han L, Sun S, Sun T. PMID: 41321049 [PubMed - as supplied by publisher]
	Targeting TET enzymes in ovarian cancer: epigenetic regulation, chemoresistance, and therapeutic opportunities. Epigenomics Shruptha P, Poyya J, Vasudevan TG, Satyamoorthy K. PMID: 41321016 [PubMed - as supplied by publisher]
	Dickkopf1 as a Potential Biomarker in Polycystic Ovary Syndrome and Insulin Resistance: A Cross-Sectional Study. J Diabetes Ling J, Wang H, Liu R, Xiao J, Qiu S, Lei X, Yang M, Lai Y, Huang H, Liang Z. PMID: 41320970 [PubMed - indexed for MEDLINE]
	Small cell neuroendocrine carcinoma of the cervix: diagnostic challenges and emerging molecular insights(â€ ). J Pathol Charbel A, Akiki G, Diwan SS, Leung SOA, Kommoss FK, Tessier-Cloutier B. PMID: 41320640 [PubMed - as supplied by publisher]
	Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival. ESMO Open Crown J, Stroyakovskii D, Yardley DA, Huang CS, Fasching PA, Bardia A, Chia S, Im SA, Martin M, Xu B, Barrios CH, Untch M, Moroose R, Hurvitz SA, Hortobagyi GN, Slamon DJ, Visco F, Spera G, Zarate JP, Halligan D, Li Z, Loi S. PMID: 41320342 [PubMed - indexed for MEDLINE]
	Novel Approaches for Detecting TP53 Mutations and Targeted Therapeutic Strategies: Emerging Insights Into Cytoplasmic p53 Aggregates in Ovarian Cancer. J Obstet Gynaecol Res Iwahashi N, Ino K. PMID: 41320175 [PubMed - indexed for MEDLINE]
	Volatile organic compound signatures in breast cancer: A pilot study on cell-based detection. Clin Chim Acta Tenorio-Salazar AJ, Orduña-Medina FM, Mizaikoff B, Mitrovics J, de León-Martínez LD, Alcántara-Quintana LE. PMID: 41319908 [PubMed - as supplied by publisher]
	Progress in nanotechnology-based strategies to enhance tamoxifen therapy for breast cancer management. Pathol Res Pract Mangu K, Gandhi AN, Rizwanullah M. PMID: 41319556 [PubMed - as supplied by publisher]
	The impact of social determinants of health on mental and behavioral health trajectories of breast cancer survivors: A longitudinal cohort study. Eur J Oncol Nurs Franco-Rocha OY, Fuentes-Balderrama J, Sun B, Smits JAJ, Magnuson A, Kesler SR, Van Dyk K, Moore RC, Henneghan AM. PMID: 41319526 [PubMed - as supplied by publisher]
	Evaluation of the 1021-HRD assay compared to established HRD testing platforms in ovarian cancer. Transl Oncol Papadopoulou E, Fountzilas E, Metaxa-Mariatou V, Tsantikidi A, Tsaousis G, Meintani A, Florou-Chatzigiannidou C, Maxouri S, Papazisis K, Floros T, Papadimitriou C, Timotheadou E, Papadopoulou K, Papathanasiou A, Grigoriadis D, Fu X, Zheng X, Xing Y, Du X, Truican A, Nasioulas G. PMID: 41319389 [PubMed - as supplied by publisher]
	Phase Separation of PHLDB2 Drives EMT and Tumor Progression in Triple-Negative Breast Cancer. Cancer Med Zhang M, Liang C, Chen T, Shi X, Hao J. PMID: 41319208 [PubMed - indexed for MEDLINE]
	Leveraging HIV prevention programs for breast cancer interventions: A survey of women stakeholders in the informal work sector in Nigeria. Womens Health (Lond) Oluwasanu M, Ibraheem A, Wang Y, Odukoya OA, Ogundipe RO, Oluwasanu AO, Adejumo P, Oladepo O, Huo D, Olopade OI. PMID: 41319006 [PubMed - indexed for MEDLINE]
	Preliminary Outcomes of a Culturally Adapted Fear of Recurrence Therapy (FORT) for Turkish Breast Cancer Survivors: A Randomized Controlled Trial. Psychooncology Eyrenci A, Ertuna L, Bahçivan O. PMID: 41318944 [PubMed - indexed for MEDLINE]
	ASCL2 contributes to clinical assessments of breast cancer and mediates tumor progression via the interaction with CLDN3. Sci Rep Yin Y, Meng Q, Liu X, Xu F, Li Y, Han X, Guo Q, Lv Y. PMID: 41318809 [PubMed - as supplied by publisher]
	A novel four-serum marker model for early detection and therapeutic monitoring of breast cancer. Sci Rep Chen S, Zeng J, Gong K, Liu Y, Long S, Han L, Luo D. PMID: 41318767 [PubMed - as supplied by publisher]
	Pregnancy-associated breast cancer: gestational weight gain impact and nomogram validation. BMC Cancer Liu C, Wang R, Wang S, Liu S, Wu X, Zheng W, Li S, Yu T, Hao J, Zhang L. PMID: 41318535 [PubMed - as supplied by publisher]
	Mapping Knowledge Landscapes and Emerging Trends in Contrast-Enhanced Ultrasound for Breast Cancer: A Bibliometric and Visualization Analysis. Ultrasound Med Biol Wang C, Hu Z, Li X, Ding Y, Zhang C. PMID: 41318251 [PubMed - as supplied by publisher]
	Efficacy and Safety of Oral 5-FU Derivatives After Progression of HR(+)/HER2(-) Metastatic Breast Cancer on CDK4/6 Inhibitor. Anticancer Res Koi Y, Tajiri W, Kawasaki J, Akiyoshi S, Ijichi H, Nakamura Y, Koga C, Tokunaga E. PMID: 41318158 [PubMed - indexed for MEDLINE]
	Comparative Analysis of FDG-PET Versus CT/MRI in Staging and Management of Advanced-stage Cervical Cancer. Anticancer Res Nayab M, Elnaggar M, Asher V, Bali A, Abdul S, Persic M, Phillips A. PMID: 41318157 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 321092

Page 1 of 16055



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy